The Main Pharmaceutical Inspector decided to suspend the national market of the medicinal product: Sumilar HCT (Ramiprilum + Amlodipinum + Hydrochlorothiazidum), 5 mg + 5 mg + 12.5 m...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in